Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Parkinson's Disease

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 324 articles:
HTML format



Single Articles


    June 2021
  1. PRASUHN J, Prasuhn M, Fellbrich A, Strautz R, et al
    Association of Locus Coeruleus and Substantia Nigra Pathology With Cognitive and Motor Functions in Patients With Parkinson Disease.
    Neurology. 2021 Jun 29. pii: WNL.0000000000012444.
    PubMed     Abstract available



  2. Cross-Sectional Profile of Most Bothersome Problems as Reported Directly by Individuals With Parkinson's Disease (2697).
    Neurology. 2021 Jun 22. pii: WNL.0000000000012412.
    PubMed    


  3. BOVE F, Mulas D, Cavallieri F, Castrioto A, et al
    Long-term Outcomes (15 Years) After Subthalamic Nucleus Deep Brain Stimulation in Patients With Parkinson Disease.
    Neurology. 2021 Jun 2. pii: WNL.0000000000012246.
    PubMed     Abstract available


    May 2021
  4. GANDHI AB, Onukwugha E, Albarmawi H, Johnson A, et al
    Healthcare Resource Utilization Associated With Parkinson Disease Among Medicare Beneficiaries.
    Neurology. 2021 May 27. pii: WNL.0000000000012290.
    PubMed     Abstract available


  5. SHIN JH, Lee JY, Kim YK, Yoon EJ, et al
    Parkinson Disease-Related Brain Metabolic Patterns and Neurodegeneration in Isolated REM Sleep Behavior Disorder.
    Neurology. 2021 May 19. pii: WNL.0000000000012228.
    PubMed     Abstract available


  6. BEACH T, Chahine LM, Adler CH, Mollenhauer B, et al
    Author Response: In Vivo Distribution of alpha-Synuclein in Multiple Tissues and Biofluids in Parkinson Disease.
    Neurology. 2021;96:965-967.
    PubMed    


  7. GIBBONS C, Donadio V, Sommer C, Liguori R, et al
    Reader Response: In Vivo Distribution of alpha-Synuclein in Multiple Tissues and Biofluids in Parkinson Disease.
    Neurology. 2021;96:964-965.
    PubMed    


  8. IRWIN D, Saint-Hilaire M
    In Vivo Detection of Underlying Synucleinopathies: Are We There Yet?
    Neurology. 2021;96:925-926.
    PubMed    


  9. DONADIO V, Wang Z, Incensi A, Rizzo G, et al
    In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC.
    Neurology. 2021;96:e2513-e2524.
    PubMed     Abstract available


  10. MCCUSKER EA, Loy CT
    Prevalent Nonmotor Symptoms Associated With Huntington Disease: Challenging to Interpret and With Early Impact on Function.
    Neurology. 2021;96:875-876.
    PubMed    


  11. KIM R, Park S, Yoo D, Jun JS, et al
    Association of Physical Activity and APOE Genotype With Longitudinal Cognitive Change in Early Parkinson Disease.
    Neurology. 2021;96:e2429-e2437.
    PubMed     Abstract available


  12. HONG Z, Tian C, Stewart T, Aro P, et al
    Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying alpha-Synuclein-Containing Extracellular Vesicles.
    Neurology. 2021;96:e2332-e2345.
    PubMed     Abstract available


    April 2021
  13. RIOU A, Houvenaghel JF, Dondaine T, Drapier S, et al
    Functional Role of the Cerebellum in Parkinson Disease: A PET Study.
    Neurology. 2021 Apr 28. pii: WNL.0000000000012036.
    PubMed     Abstract available


  14. DONG Y, Cheng X, Dong Q
    Teaching NeuroImages: Parkinsonism Presenting With Watershed Pattern Lesions.
    Neurology. 2021 Apr 26. pii: WNL.0000000000012056.
    PubMed    


  15. LAMOTTE G, Benarroch EE
    What Is the Clinical Correlation of Cardiac Noradrenergic Denervation in Parkinson Disease?
    Neurology. 2021;96:748-753.
    PubMed    


    March 2021
  16. RABER J, Darweesh SKL, Savica R
    Physical Activity May Reduce Apolipoprotein E4-Associated Cognitive Decline in Parkinson Disease.
    Neurology. 2021 Mar 31. pii: WNL.0000000000011851.
    PubMed    


  17. TANG X, Zhang Y, Liu D, Hu Y, et al
    Association of Gyrification Pattern, White Matter Changes, and Phenotypic Profile in Patients With Parkinson Disease.
    Neurology. 2021 Mar 25. pii: WNL.0000000000011894.
    PubMed     Abstract available


  18. HACKER ML, Konrad PE, Davis TL, Charles D, et al
    Author Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes.
    Neurology. 2021;96:592.
    PubMed    


  19. SIDIROPOULOS C
    Reader Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes.
    Neurology. 2021;96:591-592.
    PubMed    


  20. CHARLES D, Hacker ML, Davis TL, Konrad PE, et al
    Author Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes.
    Neurology. 2021;96:591.
    PubMed    


  21. FASANO A, Bhowmick SS
    Reader Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes.
    Neurology. 2021;96:590-591.
    PubMed    


  22. SIEGLER JE, Galetta S
    Editors' Note: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes.
    Neurology. 2021;96:590.
    PubMed    


  23. CHUNG SJ, Yoo HS, Shin NY, Park YW, et al
    Perivascular Spaces in the Basal Ganglia and Long-term Motor Prognosis in Newly Diagnosed Parkinson Disease.
    Neurology. 2021 Mar 2. pii: WNL.0000000000011797.
    PubMed     Abstract available


    February 2021
  24. LO C, Arora S, Ben-Shlomo Y, Barber TR, et al
    Olfactory Testing in Parkinson's Disease & REM Behavior Disorder: A Machine Learning Approach.
    Neurology. 2021 Feb 24. pii: WNL.0000000000011743.
    PubMed     Abstract available


  25. KANG X, Ploner A, Pedersen NL, Bandres-Ciga S, et al
    Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study.
    Neurology. 2021 Feb 19. pii: WNL.0000000000011630.
    PubMed     Abstract available


  26. PARK KW, Lee EJ, Lee JS, Jeong J, et al
    Machine Learning Based Automatic Rating for Cardinal Symptoms of Parkinson.
    Neurology. 2021 Feb 10. pii: WNL.0000000000011654.
    PubMed     Abstract available


  27. PARK JH, Lee CW, Nam MJ, Kim H, et al
    Association of High-density Lipoprotein Cholesterol Variability and the Risk of Developing Parkinson's Disease.
    Neurology. 2021 Feb 3. pii: WNL.0000000000011553.
    PubMed     Abstract available


  28. PES GM, Park YM, Sechi GP
    Cholesterol trafficking in the brain: Are we overlooking an important risk factor for Parkinson's disease?
    Neurology. 2021 Feb 3. pii: WNL.0000000000011595.
    PubMed    


    January 2021
  29. HANTIKAINEN E, Lagerros YT, Ye W, Serafini M, et al
    Dietary antioxidants and the risk of Parkinson Disease: The Swedish National March Cohort.
    Neurology. 2021 Jan 6. pii: WNL.0000000000011373.
    PubMed     Abstract available


    December 2020

  30. Correction: Cultural disparities in deep brain stimulation (DBS) decision making in patients with Parkinson disease (PD) (1713).
    Neurology. 2020 Dec 22. pii: WNL.0000000000011240.
    PubMed    


  31. MAPLE-GRODEM J, Dalen I, Tysnes OB, Macleod AD, et al
    Association of GBA Genotype with Motor and Functional Decline in Newly Diagnosed Patients with Parkinsons Disease.
    Neurology. 2020 Dec 21. pii: WNL.0000000000011411.
    PubMed     Abstract available


  32. SHIN JH, Lee JY, Kim YK, Shin SA, et al
    Longitudinal change in dopamine transporter availability in idiopathic REM sleep behavior disorder.
    Neurology. 2020;95:e3081-e3092.
    PubMed     Abstract available


  33. PYATIGORSKAYA N, Yahia-Cherif L, Valabregue R, Gaurav R, et al
    Parkinson Disease Propagation Using MRI Biomarkers and Partial Least Squares Path Modeling.
    Neurology. 2020 Dec 4. pii: WNL.0000000000011155.
    PubMed     Abstract available


    November 2020
  34. BECKER S, Granert O, Timmers M, Pilotto A, et al
    Association of hippocampal subfields, CSF biomarkers and cognition in non-demented Parkinson's disease patients.
    Neurology. 2020 Nov 20. pii: WNL.0000000000011224.
    PubMed     Abstract available


  35. HIRATA K, Yokota T, Miura Y
    Teaching-Neuroimages: Parkinsonism secondary to a metastatic lesion involving the substantia nigra.
    Neurology. 2020 Nov 9. pii: WNL.0000000000011162.
    PubMed    


    October 2020
  36. WALDVOGEL D, Baumann CR
    Author response: Beware of deep water after subthalamic deep brain stimulation.
    Neurology. 2020;95:760.
    PubMed    


  37. SIDIROPOULOS C
    Reader response: Beware of deep water after subthalamic deep brain stimulation.
    Neurology. 2020;95:759-760.
    PubMed    


  38. WALDVOGEL D, Baumann CR
    Author response: Beware of deep water after subthalamic deep brain stimulation.
    Neurology. 2020;95:759.
    PubMed    


  39. BOUCA-MACHADO R, Neves M, Pona-Ferreira F, Ferreira JJ, et al
    Reader response: Beware of deep water after subthalamic deep brain stimulation.
    Neurology. 2020;95:758-759.
    PubMed    


  40. TAN AH, Lim SY, Chong KK, Azhan A Manap MA, et al
    Probiotics for constipation in Parkinson's disease: A randomized placebo-controlled study.
    Neurology. 2020 Oct 12. pii: WNL.0000000000010998.
    PubMed     Abstract available


  41. LIN CH, Chiu MJ
    Author response: Blood NfL: A biomarker for disease severity and progression in Parkinson disease.
    Neurology. 2020;95:658.
    PubMed    


  42. VAN RUMUND A, Marques TM, Esselink RAJ, Bloem BR, et al
    Reader response: Blood NfL: A biomarker for disease severity and progression in Parkinson disease.
    Neurology. 2020;95:657-658.
    PubMed    


  43. LEWIS A, Galetta S
    Editors' note: Blood NfL: A biomarker for disease severity and progression in Parkinson disease.
    Neurology. 2020;95:657.
    PubMed    


  44. FRIEDMAN JH, Goetz CG
    Apathy in Parkinson's disease: Why we should care.
    Neurology. 2020 Oct 1. pii: WNL.0000000000010961.
    PubMed    


  45. SCOTT BM, Eisinger RS, Burns MR, Lopes J, et al
    Co-occurrence of apathy and impulse control disorders in Parkinson's disease.
    Neurology. 2020 Oct 1. pii: WNL.0000000000010965.
    PubMed     Abstract available


    September 2020
  46. CROTTY GF, Maciuca R, Macklin EA, Wang J, et al
    Association of caffeine and related analytes with resistance to Parkinson's disease among LRRK2 mutation carriers: A metabolomic study.
    Neurology. 2020 Sep 30. pii: WNL.0000000000010863.
    PubMed     Abstract available


  47. POSTUMA RB
    Dopamine imaging in prodromal Parkinson disease trials: Ready for prime time?
    Neurology. 2020 Sep 28. pii: WNL.0000000000010957.
    PubMed    


  48. CHUNG SJ, Lee HS, Kim HR, Yoo HS, et al
    Factor analysis-derived cognitive profile predicting early dementia conversion in PD.
    Neurology. 2020;95:e1650-e1659.
    PubMed     Abstract available


  49. GOLBE L
    A new sorting hat for Parkinson disease.
    Neurology. 2020 Sep 17. pii: WNL.0000000000010819.
    PubMed    


  50. DANIELE B, Roberta P, Andrea F, Matteo C, et al
    Risk factors of Parkinson's disease: Simultaneous assessment, interactions and etiological subtypes.
    Neurology. 2020 Sep 17. pii: WNL.0000000000010813.
    PubMed     Abstract available


  51. ALESSANDRA F, Campese N, Goebel G, Ndayisaba JP, et al
    Association of transient orthostatic hypotension with falls and syncope in patients with Parkinson's disease.
    Neurology. 2020 Sep 16. pii: WNL.0000000000010749.
    PubMed     Abstract available


    August 2020
  52. BREEN DP, Munoz DG, Lang AE
    Twinkle-associated familial parkinsonism with Lewy pathology: Cause or predisposition?
    Neurology. 2020 Aug 26. pii: WNL.0000000000010674.
    PubMed     Abstract available


  53. MOLSBERRY S, Bjornevik K, Hughes KC, Healy B, et al
    Diet pattern and prodromal features of Parkinson's disease.
    Neurology. 2020 Aug 19. pii: WNL.0000000000010523.
    PubMed     Abstract available


  54. COON EA, Mandrekar JN, Berini SE, Benarroch EE, et al
    Predicting phenoconversion in pure autonomic failure.
    Neurology. 2020;95:e889-e897.
    PubMed     Abstract available


  55. LAMOTTE G, Becker B
    Towards biomarker-based clinical subtyping of Parkinson's disease.
    Neurology. 2020 Aug 14. pii: WNL.0000000000010496.
    PubMed    


  56. WANG L, Cheng W, Rolls E, Dai F, et al
    Association of specific biotypes in patients with Parkinson disease and disease progression.
    Neurology. 2020 Aug 14. pii: WNL.0000000000010498.
    PubMed     Abstract available


  57. CHAHINE LM, Beach TG, Brumm MC, Adler CH, et al
    In vivo distribution of alpha-synuclein in multiple tissues and biofluids in Parkinson disease.
    Neurology. 2020 Aug 3. pii: WNL.0000000000010404.
    PubMed     Abstract available


    July 2020
  58. KARCESKI S
    Parkinson disease: The long-term benefits of early use of deep brain stimulation.
    Neurology. 2020;95:e436-e438.
    PubMed    


  59. CEREDA E, Barichella M, Pezzoli G
    Author response: Muscle-targeted nutritional support for rehabilitation in patients with parkinsonian syndrome.
    Neurology. 2020;95:143.
    PubMed    


  60. LOPEZ BOTELLO CK, Estrada-Bellmann I, Castillo-Torres SA, Martinez-Roque DG, et al
    Reader response: Muscle-targeted nutritional support for rehabilitation in patients with parkinsonian syndrome.
    Neurology. 2020;95:142-143.
    PubMed    


  61. GANESH A, Galetta S
    Editors' note: Muscle-targeted nutritional support for rehabilitation in patients with parkinsonian syndrome.
    Neurology. 2020;95:142.
    PubMed    


  62. SHINOTOH H, Tokuda T
    Systemic synuclein sampling study toward a Parkinson's disease biomarker: Final results?
    Neurology. 2020 Jul 20. pii: WNL.0000000000010428.
    PubMed    


  63. BACKSTROM D, Linder J, Mo SJ, Riklund K, et al
    NfL as a biomarker for neurodegeneration and survival in Parkinson disease.
    Neurology. 2020 Jul 17. pii: WNL.0000000000010084.
    PubMed     Abstract available


  64. HERMAN C, Mayer K, Sarwal A
    Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19.
    Neurology. 2020;95:77-84.
    PubMed     Abstract available


  65. ZACH H, Dirkx MF, Roth D, Pasman JW, et al
    Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease.
    Neurology. 2020 Jul 10. pii: WNL.0000000000010316.
    PubMed     Abstract available


  66. CHUNG SJ, Lee HS, Yoo HS, Lee YH, et al
    Patterns of striatal dopamine depletion in early Parkinson disease: Prognostic relevance.
    Neurology. 2020 Jul 2. pii: WNL.0000000000009878.
    PubMed     Abstract available


  67. BOVE F, Fraix V, Cavallieri F, Schmitt E, et al
    Dementia and subthalamic deep brain stimulation in Parkinson disease: A long-term overview.
    Neurology. 2020 Jul 1. pii: WNL.0000000000009822.
    PubMed     Abstract available


    June 2020
  68. HACKER ML, Turchan M, Heusinkveld LE, Currie AD, et al
    Deep Brain Stimulation in Early-Stage Parkinson's Disease: Five Year Outcomes.
    Neurology. 2020 Jun 29. pii: WNL.0000000000009946.
    PubMed     Abstract available


  69. LEE Y, Ko J, Choi YE, Oh JS, et al
    Areas of white matter hyperintensities and motor symptoms of Parkinson disease.
    Neurology. 2020 Jun 23. pii: WNL.0000000000009890.
    PubMed     Abstract available


  70. HUH YE, Ruby Chiang MS, Locascio JJ, Liao Z, et al
    beta-Glucocerebrosidase Activity in GBA-linked Parkinson's Disease: The Type of Mutation Matters.
    Neurology. 2020 Jun 15. pii: WNL.0000000000009989.
    PubMed     Abstract available


    May 2020
  71. MODICA JS, Bonno D, Lizarraga KJ
    Pearls and Oy-sters: Vitamin B6 deficiency presenting with new-onset epilepsy and status epilepticus in a patient with Parkinson disease.
    Neurology. 2020 May 28. pii: WNL.0000000000009647.
    PubMed    


  72. NARENDRA DP, Isonaka R, Nguyen D, Schindler AB, et al
    Author response: Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss.
    Neurology. 2020;94:944.
    PubMed    


  73. NAMNAH M, Elpeleg O, Gotkine M, Arkadir D, et al
    Reader response: Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss.
    Neurology. 2020;94:943-944.
    PubMed    


  74. GANESH A, Galetta S
    Editors' note: Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss.
    Neurology. 2020;94:943.
    PubMed    


  75. POTTEGARD A, Hopfner F, Wod M, Hoglinger GU, et al
    Author response: Use of beta2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.
    Neurology. 2020;94:899.
    PubMed    


  76. SCHERZER CR, Riise T, Locascio JJ
    Reader response: Use of beta2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.
    Neurology. 2020;94:898-899.
    PubMed    


  77. SIEGLER JE 3RD, Galetta S
    Editors' note: Use of beta2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.
    Neurology. 2020;94:897-898.
    PubMed    


  78. SCHAEFFER E, Rogge A, Nieding K, Helmker V, et al
    Patients' views on the ethical challenges of early Parkinson disease detection.
    Neurology. 2020;94:e2037-e2044.
    PubMed     Abstract available


  79. MAPPIN-KASIRER B, Pan H, Lewington S, Kizza J, et al
    Tobacco smoking and the risk of Parkinson disease: A 65-year follow-up of 30,000 male British doctors.
    Neurology. 2020 May 5. pii: WNL.0000000000009437.
    PubMed     Abstract available


  80. CHENG Y, Wang YJ
    Tobacco smoking and the reduced risk of Parkinson disease: A puzzle of 60 years.
    Neurology. 2020 May 5. pii: WNL.0000000000009431.
    PubMed    


    April 2020
  81. CAMACHO-SOTO A, Gross A, Searles Nielsen S, Miller AN, et al
    Fractures in the prodromal period of Parkinson disease.
    Neurology. 2020 Apr 28. pii: WNL.0000000000009452.
    PubMed     Abstract available


  82. ARMSTRONG MJ, Emre M
    Dementia with Lewy bodies and Parkinson disease dementia: More different than similar?
    Neurology. 2020 Apr 24. pii: WNL.0000000000009433.
    PubMed    


  83. SMIRNOV DS, Galasko D, Edland SD, Filoteo JV, et al
    Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies.
    Neurology. 2020 Apr 24. pii: WNL.0000000000009434.
    PubMed     Abstract available


  84. HUANG X, Gilbert GJ
    Psychosis in Parkinson disease: White matter matters.
    Neurology. 2020 Apr 21. pii: WNL.0000000000009368.
    PubMed    


  85. LENKA A, Ingalhalikar M, Shah A, Saini J, et al
    Abnormalities in the white matter tracts in patients with Parkinson disease and psychosis.
    Neurology. 2020 Apr 21. pii: WNL.0000000000009363.
    PubMed     Abstract available


  86. IRANZO A, Stefani A, Ninerola-Baizan A, Stokner H, et al
    Left-hemispheric predominance of nigrostriatal deficit in isolated REM sleep behavior disorder.
    Neurology. 2020;94:e1605-e1613.
    PubMed     Abstract available


  87. PONTONE GM, Mills KA
    A call for better depression treatment in people with Parkinson disease.
    Neurology. 2020 Apr 1. pii: WNL.0000000000009285.
    PubMed    


  88. DOBKIN RD, Mann SL, Gara MA, Interian A, et al
    Telephone-based cognitive behavioral therapy for depression in Parkinson disease: A randomized controlled trial.
    Neurology. 2020 Apr 1. pii: WNL.0000000000009292.
    PubMed     Abstract available


    March 2020
  89. REYNOLDS EL, Burke JF, Banerjee M, Kerber KA, et al
    Association of out-of-pocket costs on adherence to common neurologic medications.
    Neurology. 2020;94:e1415-e1426.
    PubMed     Abstract available


  90. MCDONALD C, Rees J, Winge K, Newton JL, et al
    Bladder training for urinary tract symptoms in Parkinson disease: A randomized controlled trial.
    Neurology. 2020;94:e1427-e1433.
    PubMed     Abstract available



  91. Retraction: High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease.
    Neurology. 2020 Mar 30. pii: WNL.0000000000009358.
    PubMed    


  92. BORM CDJM, Visser F, Werkmann M, de Graaf D, et al
    Seeing ophthalmologic problems in Parkinson disease: Results of a visual impairment questionnaire.
    Neurology. 2020 Mar 11. pii: WNL.0000000000009214.
    PubMed     Abstract available


  93. DEUSCHL G, Schuepbach MWM, Schade-Brittinger C, Tonder L, et al
    Author response: Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.
    Neurology. 2020;94:413.
    PubMed    


  94. SIDIROPOULOS C
    Reader response: Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.
    Neurology. 2020;94:412.
    PubMed    


  95. SIEGLER JE 3RD, Galetta S
    Editors' note: Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.
    Neurology. 2020;94:411-412.
    PubMed    


    February 2020
  96. ESPAY AJ, Kalia LV, Gan-Or Z, Williams-Gray CH, et al
    Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?
    Neurology. 2020 Feb 26. pii: WNL.0000000000009107.
    PubMed     Abstract available


  97. AHLSKOG JE
    Considerations for trials of disease modifying treatments in Parkinson disease.
    Neurology. 2020 Feb 26. pii: WNL.0000000000009127.
    PubMed    


  98. HASAN S, Mielke MM, Turcano P, Ahlskog JE, et al
    Traumatic brain injury preceding clinically diagnosed alpha-synucleinopathies: A case-control study.
    Neurology. 2020;94:e764-e773.
    PubMed     Abstract available


  99. ZARKALI A, McColgan P, Leyland LA, Lees AJ, et al
    Fiber-specific white matter reductions in Parkinson hallucinations and visual dysfunction.
    Neurology. 2020 Feb 24. pii: WNL.0000000000009014.
    PubMed     Abstract available


    January 2020
  100. ESPAY AJ, Vizcarra JA, Marsili L, Lang AE, et al
    Author response: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2020;94:144-145.
    PubMed    


  101. NELSON P
    Reader response: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2020;94:143-144.
    PubMed    


  102. SIEGLER JE 3RD, Galetta S
    Editors' note: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2020;94:143.
    PubMed    


  103. WALDVOGEL D, Baumann-Vogel H, Stieglitz L, Hanggi-Schickli R, et al
    Beware of deep water after subthalamic deep brain stimulation.
    Neurology. 2020;94:39-41.
    PubMed    


    December 2019
  104. MISHRA VR, Sreenivasan KR, Yang Z, Zhuang X, et al
    Unique white matter structural connectivity in early-stage, drug-naive Parkinson disease.
    Neurology. 2019 Dec 27. pii: WNL.0000000000008867.
    PubMed     Abstract available


  105. CAMPBELL MC, Jackson JJ, Koller JM, Snyder AZ, et al
    Proteinopathy and longitudinal changes in functional connectivity networks in Parkinson disease.
    Neurology. 2019 Dec 18. pii: WNL.0000000000008677.
    PubMed     Abstract available


  106. MAITI B, Koller JM, Snyder AZ, Tanenbaum AB, et al
    Cognitive correlates of cerebellar resting-state functional connectivity in Parkinson disease.
    Neurology. 2019 Dec 17. pii: WNL.0000000000008754.
    PubMed     Abstract available


    November 2019
  107. ZHOU Z, Muller MLTM, Kanel P, Chua J, et al
    Apathy rating scores and beta-amyloidopathy in Parkinson disease patients at risk for cognitive decline.
    Neurology. 2019 Nov 15. pii: WNL.0000000000008683.
    PubMed     Abstract available


  108. HUGHES KC, Gao X, Molsberry S, Valeri L, et al
    Physical activity and prodromal features of Parkinson disease.
    Neurology. 2019 Nov 12. pii: WNL.0000000000008567.
    PubMed     Abstract available


    October 2019

  109. Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.
    Neurology. 2019;93:725.
    PubMed    


  110. ABBOTT RD, Ross GW, Duda JE, Shin C, et al
    Excessive daytime sleepiness and topographic expansion of Lewy pathology.
    Neurology. 2019;93:e1425-e1432.
    PubMed     Abstract available


  111. SCHWARZSCHILD MA, Macklin EA, Bakshi R, Battacharyya S, et al
    Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial.
    Neurology. 2019;93:e1328-e1338.
    PubMed     Abstract available


    September 2019
  112. URSO D, Monje MHG, Piredda R, Ortu R, et al
    Clinical Reasoning: A 58-year-old man with hand tremor and episodes of neck pain.
    Neurology. 2019;93:557-561.
    PubMed    


  113. MCCARTER SJ, Sandness DJ, McCarter AR, Feemster JC, et al
    REM sleep muscle activity in idiopathic REM sleep behavior disorder predicts phenoconversion.
    Neurology. 2019;93:e1171-e1179.
    PubMed     Abstract available


  114. SAVICA R
    Livin' on the edge: Risky behaviors and Parkinson disease: Genes, environment, or both?
    Neurology. 2019 Sep 16. pii: WNL.0000000000008236.
    PubMed    


  115. GROVER S, Lill CM, Kasten M, Klein C, et al
    Risky behaviors and Parkinson disease: A mendelian randomization study.
    Neurology. 2019 Sep 16. pii: WNL.0000000000008245.
    PubMed     Abstract available


  116. HIORTH YH, Pedersen KF, Dalen I, Tysnes OB, et al
    Orthostatic hypotension in Parkinson disease: A 7-year prospective population-based study.
    Neurology. 2019 Sep 16. pii: WNL.0000000000008314.
    PubMed     Abstract available


  117. CHAMORRO A, Mir P
    Raising serum urate levels in Parkinson disease: A strategy only for women?
    Neurology. 2019 Sep 4. pii: WNL.0000000000008191.
    PubMed    


    August 2019
  118. DEUEL L, Collins AE, Maa EH, Barr JP, et al
    Dravet syndrome and parkinsonism: A case report investigating the dopaminergic system.
    Neurology. 2019 Aug 23. pii: WNL.0000000000008171.
    PubMed    


  119. LIN CH, Li CH, Yang KC, Lin FJ, et al
    Blood NfL: A biomarker for disease severity and progression in Parkinson disease.
    Neurology. 2019 Aug 16. pii: WNL.0000000000008088.
    PubMed     Abstract available


  120. BOYLAN LS, Chio A
    Divining progression in Parkinson disease with a blood test: NfL.
    Neurology. 2019 Aug 16. pii: WNL.0000000000008087.
    PubMed    


  121. HWANG J, Bank AM, Mortazavi F, Oakley DH, et al
    Spinal cord alpha-synuclein deposition associated with myoclonus in patients with MSA-C.
    Neurology. 2019;93:302-309.
    PubMed     Abstract available


  122. BACKSTROM D, Domellof ME, Forsgren L
    Author response: Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
    Neurology. 2019;93:279.
    PubMed    


  123. KELLER DL
    Reader response: Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
    Neurology. 2019;93:279.
    PubMed    


  124. SIEGLER JE 3RD, Galetta S
    Editors' note: Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
    Neurology. 2019;93:278.
    PubMed    


  125. SHIN JH, Park KW, Heo KO, Chung SJ, et al
    Urodynamic study for distinguishing multiple system atrophy from Parkinson disease.
    Neurology. 2019 Aug 1. pii: WNL.0000000000008053.
    PubMed     Abstract available


    July 2019
  126. YOON EJ, Ismail Z, Hanganu A, Kibreab M, et al
    Mild behavioral impairment is linked to worse cognition and brain atrophy in Parkinson disease.
    Neurology. 2019 Jul 18. pii: WNL.0000000000007968.
    PubMed     Abstract available


  127. BAIG F, Kelly MJ, Lawton MA, Ruffmann C, et al
    Impulse control disorders in Parkinson and RBD: A longitudinal study of severity.
    Neurology. 2019 Jul 16. pii: WNL.0000000000007942.
    PubMed     Abstract available


  128. LENKA A, Pagonabarraga J, Pal PK, Bejr-Kasem H, et al
    Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.
    Neurology. 2019 Jul 9. pii: WNL.0000000000007913.
    PubMed     Abstract available


  129. LEE MJ, Pak K, Kim JH, Kim YJ, et al
    Effect of polygenic load on striatal dopaminergic deterioration in Parkinson disease.
    Neurology. 2019 Jul 9. pii: WNL.0000000000007939.
    PubMed     Abstract available


  130. BARICHELLA M, Cereda E, Pinelli G, Iorio L, et al
    Muscle-targeted nutritional support for rehabilitation in patients with parkinsonian syndrome.
    Neurology. 2019 Jul 5. pii: WNL.0000000000007858.
    PubMed     Abstract available


    June 2019
  131. SHIRVAN J, Clement N, Ye R, Katz S, et al
    Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease.
    Neurology. 2019 Jun 26. pii: WNL.0000000000007855.
    PubMed     Abstract available



  132. Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.
    Neurology. 2019;92:1166.
    PubMed    


  133. GERA A, Witek N, Bailey M
    Pearls & Oy-sters: CAA-related inflammation presents as subacute cognitive decline in a patient with Parkinson disease.
    Neurology. 2019;92:1116-1118.
    PubMed    


    May 2019
  134. HOPFNER F, Wod M, Hoglinger GU, Blaabjerg M, et al
    Use of beta2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.
    Neurology. 2019 May 24. pii: WNL.0000000000007694.
    PubMed     Abstract available


  135. PONTONE GM, Koch G
    An association between bipolar disorder and Parkinson disease: When mood makes you move.
    Neurology. 2019 May 22. pii: WNL.0000000000007641.
    PubMed    


  136. HUANG MH, Cheng CM, Huang KL, Hsu JW, et al
    Bipolar disorder and risk of Parkinson disease: A nationwide longitudinal study.
    Neurology. 2019 May 22. pii: WNL.0000000000007649.
    PubMed     Abstract available


  137. GIANNINI G, Francois M, Lhommee E, Polosan M, et al
    Suicide and suicide attempts after subthalamic nucleus stimulation in Parkinson disease.
    Neurology. 2019 May 17. pii: WNL.0000000000007665.
    PubMed     Abstract available


  138. ALONSO-NAVARRO H, Garcia-Martin E, Agundez JAG, Jimenez-Jimenez FJ, et al
    Association between restless legs syndrome and other movement disorders.
    Neurology. 2019;92:948-964.
    PubMed     Abstract available


  139. DE PABLO-FERNANDEZ E, Warner T
    Author response: Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
    Neurology. 2019;92:925-926.
    PubMed    


  140. LAI SW
    Reader response: Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
    Neurology. 2019;92:925.
    PubMed    


  141. GANESH A, Galetta S
    Editors' note: Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
    Neurology. 2019;92:924.
    PubMed    


  142. LAU B, Meier N, Serra G, Czernecki V, et al
    Axial symptoms predict mortality in patients with Parkinson disease with subthalamic stimulation.
    Neurology. 2019 May 1. pii: WNL.0000000000007562.
    PubMed     Abstract available


    April 2019

  143. Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2019;92:871.
    PubMed    


  144. KLEPITSKAYA O
    Author response: Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2019;92:869.
    PubMed    


  145. MARQUES AR, Fantini ML, Durif F
    Reader response: Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2019;92:868-869.
    PubMed    


  146. GANESH A, Galetta S
    Editors' note: Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2019;92:868.
    PubMed    


  147. TUCK KK, Tarolli CG
    Palliative care and advance care planning in Parkinson disease.
    Neurology. 2019 Apr 26. pii: WNL.0000000000007555.
    PubMed    


  148. NARENDRA DP, Isonaka R, Nguyen D, Schindler AB, et al
    Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss.
    Neurology. 2019 Apr 26. pii: WNL.0000000000007614.
    PubMed    


  149. LUM HD, Jordan SR, Brungardt A, Ayele R, et al
    Framing advance care planning in Parkinson disease: Patient and care partner perspectives.
    Neurology. 2019 Apr 26. pii: WNL.0000000000007552.
    PubMed     Abstract available


  150. FORREST SL, Crockford DR, Sizemova A, McCann H, et al
    Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration.
    Neurology. 2019 Apr 24. pii: WNL.0000000000007530.
    PubMed     Abstract available


  151. JOST WH, Friedman A, Michel O, Oehlwein C, et al
    SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea.
    Neurology. 2019;92:e1982-e1991.
    PubMed     Abstract available


  152. BOUGEA A, Maraki MI, Yannakoulia M, Stamelou M, et al
    Higher probability of prodromal Parkinson disease is related to lower cognitive performance.
    Neurology. 2019 Apr 3. pii: WNL.0000000000007453.
    PubMed     Abstract available


    March 2019
  153. TRENKWALDER C, Kuoppamaki M, Vahteristo M, Muller T, et al
    Increased dose of carbidopa with levodopa and entacapone improves "off" time in a randomized trial.
    Neurology. 2019;92:e1487-e1496.
    PubMed     Abstract available


  154. YOO HS, Chung SJ, Lee YH, Lee HS, et al
    Levodopa-induced dyskinesia is closely linked to progression of frontal dysfunction in PD.
    Neurology. 2019;92:e1468-e1478.
    PubMed     Abstract available


  155. CONNOR KI, Cheng EM, Barry F, Siebens HC, et al
    Randomized trial of care management to improve Parkinson disease care quality.
    Neurology. 2019 Mar 22. pii: WNL.0000000000007324.
    PubMed     Abstract available


  156. CALABRESI P, Nigro P, Schwarz HB
    A nurse-led model increases quality of care in Parkinson disease.
    Neurology. 2019 Mar 22. pii: WNL.0000000000007295.
    PubMed    


  157. BUCHMAN AS, Yu L, Wilson RS, Leurgans SE, et al
    Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies.
    Neurology. 2019 Mar 20. pii: WNL.0000000000007315.
    PubMed     Abstract available


  158. METZER WS, Rodrigues FB
    Managing treatment fluctuations in Parkinson disease: "On" again-, "off" again.
    Neurology. 2019 Mar 1. pii: WNL.0000000000007193.
    PubMed    


    February 2019
  159. AKHTAR RS, Mano T
    High serum neurofilament light chain predicts a worse fate in early parkinsonism.
    Neurology. 2019 Feb 27. pii: WNL.0000000000007194.
    PubMed    


  160. MARQUES TM, van Rumund A, Oeckl P, Kuiperij HB, et al
    Serum NFL discriminates Parkinson disease from atypical parkinsonisms.
    Neurology. 2019 Feb 27. pii: WNL.0000000000007179.
    PubMed     Abstract available


  161. CHUNG SJ, Bae YJ, Jun S, Yoo HS, et al
    Dysautonomia is associated with structural and functional alterations in Parkinson disease.
    Neurology. 2019 Feb 22. pii: WNL.0000000000007181.
    PubMed     Abstract available


  162. VIDENOVIC A, Messinis L
    Enlightened PD: A novel treatment for Parkinson disease?
    Neurology. 2019 Feb 15. pii: WNL.0000000000007078.
    PubMed    


  163. RUTTEN S, Vriend C, Smit JH, Berendse HW, et al
    Bright light therapy for depression in Parkinson disease: A randomized controlled trial.
    Neurology. 2019 Feb 15. pii: WNL.0000000000007090.
    PubMed     Abstract available


  164. ESPAY AJ, Vizcarra JA, Marsili L, Lang AE, et al
    Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2019;92:329-337.
    PubMed     Abstract available


  165. CHEN CC
    Is outcome of subthalamic nucleus deep brain stimulation in Parkinson disease predictable?
    Neurology. 2019 Feb 8. pii: WNL.0000000000007023.
    PubMed    


  166. SCHUEPBACH WMM, Tonder L, Schnitzler A, Krack P, et al
    Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.
    Neurology. 2019 Feb 8. pii: WNL.0000000000007037.
    PubMed     Abstract available


    December 2018
  167. PRANGE S, Danaila T, Laurencin C, Caire C, et al
    Age and time course of long-term motor and nonmotor complications in Parkinson disease.
    Neurology. 2018 Dec 12. pii: WNL.0000000000006737.
    PubMed     Abstract available


    November 2018
  168. JUTTUKONDA MR, Franco G, Englot DJ, Lin YC, et al
    White matter differences between essential tremor and Parkinson disease.
    Neurology. 2018 Nov 30. pii: WNL.0000000000006694.
    PubMed     Abstract available


  169. KIM R, Lee J, Kim HJ, Kim A, et al
    CSF beta-amyloid42 and risk of freezing of gait in early Parkinson disease.
    Neurology. 2018 Nov 30. pii: WNL.0000000000006692.
    PubMed     Abstract available


  170. KARCESKI S
    Parkinson disease and mortality: Understanding how the two are connected.
    Neurology. 2018;91:e2106-e2108.
    PubMed    


  171. KOO BB
    Author response: Demoralization in Parkinson disease.
    Neurology. 2018;91:1030.
    PubMed    


  172. BRUNO V, Mancini D, Zurowski M, Miyasaki JM, et al
    Reader response: Demoralization in Parkinson disease.
    Neurology. 2018;91:1029.
    PubMed    


  173. GANESH A, Galetta S
    Editors' note: Demoralization in Parkinson disease.
    Neurology. 2018;91:1029.
    PubMed    


  174. BLEDSOE IO, Stebbins GT, Merkitch D, Goldman JG, et al
    White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease.
    Neurology. 2018 Nov 14. pii: WNL.0000000000006646.
    PubMed     Abstract available


  175. TURCANO P, Mielke MM, Bower JH, Parisi JE, et al
    Levodopa-induced dyskinesia in Parkinson disease: A population-based cohort study.
    Neurology. 2018 Nov 7. pii: WNL.0000000000006643.
    PubMed     Abstract available


    October 2018
  176. GOLBE LI, Leyton CE
    Life expectancy in Parkinson disease.
    Neurology. 2018 Oct 31. pii: WNL.0000000000006560.
    PubMed    


  177. BACKSTROM D, Granasen G, Domellof ME, Linder J, et al
    Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
    Neurology. 2018 Oct 31. pii: WNL.0000000000006576.
    PubMed     Abstract available


  178. FERRAYE MU
    Author response: The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2018;91:811.
    PubMed    


  179. VAN GERPEN JA, Tipton PW, Uitti RJ
    Reader response: The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2018;91:810-811.
    PubMed    


  180. KARAM C, Galetta S
    Editors' note: The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2018;91:810.
    PubMed    


  181. HELMICH RC, Hallett M, Dirkx MF
    Author response: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:724.
    PubMed    


  182. JANKOVIC J
    Reader response: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:723.
    PubMed    


  183. KARAM C, Galetta S
    Editors' note: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:722.
    PubMed    


  184. GERAEDTS VJ, Boon LI, Marinus J, Gouw AA, et al
    Clinical correlates of quantitative EEG in Parkinson disease: A systematic review.
    Neurology. 2018 Oct 5. pii: WNL.0000000000006473.
    PubMed     Abstract available


    September 2018
  185. MORENO GM, Gandhi R, Lessig SL, Wright B, et al
    Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine.
    Neurology. 2018 Sep 26. pii: WNL.0000000000006396.
    PubMed    


    August 2018
  186. SPERLING SA, Shah BB, Barrett MJ, Bond AE, et al
    Focused ultrasound thalamotomy in Parkinson disease: Nonmotor outcomes and quality of life.
    Neurology. 2018 Aug 29. pii: WNL.0000000000006279.
    PubMed     Abstract available


  187. ZERVOS TM, Hamani C, Schwalb JM
    MRIgFUS in tremor-dominant PD does not lead to substantial cognitive adverse events.
    Neurology. 2018 Aug 29. pii: WNL.0000000000006268.
    PubMed    


  188. ADAMS JL, La Morgia C
    The search for Parkinson disease biomarkers: Retinal thinning as a correlate of dopamine loss.
    Neurology. 2018 Aug 15. pii: WNL.0000000000006148.
    PubMed    


  189. AHN J, Lee JY, Kim TW, Yoon EJ, et al
    Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease.
    Neurology. 2018 Aug 15. pii: WNL.0000000000006157.
    PubMed     Abstract available


  190. KLEPITSKAYA O, Liu Y, Sharma S, Sillau SH, et al
    Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2018 Aug 15. pii: WNL.0000000000006162.
    PubMed     Abstract available


  191. PAGANO G, De Micco R, Yousaf T, Wilson H, et al
    REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.
    Neurology. 2018 Aug 8. pii: WNL.0000000000006134.
    PubMed     Abstract available


  192. MACLEOD AD, Myint PK, Counsell CE
    Author response: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2018;91:287.
    PubMed    


  193. MARINELLI L
    Reader response: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2018;91:286.
    PubMed    


  194. ALCAUSKAS M, Galetta S
    Editors' note: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2018;91:286.
    PubMed    


  195. THOMPSON T, Poulter D, Miles C, Solmi M, et al
    Driving impairment and crash risk in Parkinson disease: A systematic review and meta-analysis.
    Neurology. 2018 Aug 3. pii: WNL.0000000000006132.
    PubMed     Abstract available


    July 2018
  196. KARCESKI S
    Does deep brain stimulation help early or mild Parkinson disease?
    Neurology. 2018;91:e495-e497.
    PubMed    


  197. BRODSKY MA
    Author response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:241-242.
    PubMed    


  198. TROSTER AI
    Reader response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:240-241.
    PubMed    


  199. AZIZ TZ
    Editorialist response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:240.
    PubMed    


  200. SIDIROPOULOS C
    Reader response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:239-240.
    PubMed    


  201. KARAM C, Galetta S
    Editors' note: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:239.
    PubMed    


  202. FERRER P
    Author response: Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2018;91:192.
    PubMed    


  203. BHATTACHARJEE S
    Reader response: Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2018;91:191-192.
    PubMed    


  204. ALCAUSKAS M, Galetta S
    Editors' note: Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2018;91:191.
    PubMed    


  205. FIRBANK MJ, Parikh J, Murphy N, Killen A, et al
    Reduced occipital GABA in Parkinson disease with visual hallucinations.
    Neurology. 2018 Jul 18. pii: WNL.0000000000006007.
    PubMed     Abstract available


  206. ONOFRJ M, Gilbert GJ
    GABA and hallucinations in Parkinson disease: Who is that sitting on my chair?
    Neurology. 2018 Jul 18. pii: WNL.0000000000005985.
    PubMed    


  207. SEARLES NIELSEN S, Racette BA
    Author response: A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2018;91:104.
    PubMed    


  208. KAWADA T
    Reader response: A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2018;91:104.
    PubMed    


  209. ALCAUSKAS M, Galetta S
    Editors' note: A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2018;91:103.
    PubMed    


  210. NONNEKES J, Bloem BR
    Deliberate gait scissoring to overcome freezing of gait in Parkinson disease.
    Neurology. 2018;91:97.
    PubMed    


    June 2018
  211. HACKER ML, DeLong MR, Turchan M, Heusinkveld LE, et al
    Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease.
    Neurology. 2018 Jun 29. pii: WNL.0000000000005903.
    PubMed     Abstract available


  212. CORVOL JC, Artaud F, Cormier-Dequaire F, Rascol O, et al
    Longitudinal analysis of impulse control disorders in Parkinson disease.
    Neurology. 2018 Jun 20. pii: WNL.0000000000005816.
    PubMed     Abstract available


  213. DE PABLO-FERNANDEZ E, Goldacre R, Pakpoor J, Noyce AJ, et al
    Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
    Neurology. 2018 Jun 13. pii: WNL.0000000000005771.
    PubMed     Abstract available


    May 2018
  214. CHEN H
    Author response: Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2018;90:941.
    PubMed    


  215. MAHLKNECHT P, Kiechl S, Willeit J, Poewe W, et al
    Reader response: Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2018;90:940.
    PubMed    


  216. ALCAUSKAS M, Galetta S
    Editors' note: Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2018;90:940.
    PubMed    


  217. BOOT E, Butcher NJ, Udow S, Marras C, et al
    Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.
    Neurology. 2018 May 11. pii: WNL.0000000000005660.
    PubMed     Abstract available


  218. GROSS A, Racette BA, Camacho-Soto A, Dube U, et al
    Use of medical care biases associations between Parkinson disease and other medical conditions.
    Neurology. 2018 May 9. pii: WNL.0000000000005678.
    PubMed     Abstract available


  219. PALMA JA, Mano T
    Central or peripheral autonomic dysfunction in Parkinson disease: Does it matter?
    Neurology. 2018 May 4. pii: WNL.0000000000005624.
    PubMed    


    April 2018
  220. FERREIRA JJ, Lees AJ, Poewe W, Rascol O, et al
    Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease.
    Neurology. 2018 Apr 25. pii: WNL.0000000000005557.
    PubMed     Abstract available


  221. FULLARD ME, Willis AW
    Author response: Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2018;90:813.
    PubMed    


  222. BRYANT MS, Protas EJ
    Reader response: Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2018;90:812.
    PubMed    


  223. KARAM C, Galetta S
    Editors' note: Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2018;90:812.
    PubMed    


  224. GARDNER RC, Byers AL, Barnes DE, Li Y, et al
    Mild TBI and risk of Parkinson disease: A Chronic Effects of Neurotrauma Consortium Study.
    Neurology. 2018 Apr 18. pii: WNL.0000000000005522.
    PubMed     Abstract available


  225. ROOS E, Grotta A, Yang F, Bellocco R, et al
    Body mass index, sitting time, and risk of Parkinson disease.
    Neurology. 2018;90:e1413-e1417.
    PubMed     Abstract available


  226. KIM IY, O'Reilly EJ, Hughes KC, Gao X, et al
    Integration of risk factors for Parkinson disease in 2 large longitudinal cohorts.
    Neurology. 2018 Apr 11. pii: WNL.0000000000005473.
    PubMed     Abstract available


  227. PAGANO G, Polychronis S, Wilson H, Giordano B, et al
    Diabetes mellitus and Parkinson disease.
    Neurology. 2018 Apr 6. pii: WNL.0000000000005475.
    PubMed     Abstract available


  228. DAS RR, Unger MM
    Diabetes and Parkinson disease: A sweet spot?
    Neurology. 2018 Apr 6. pii: WNL.0000000000005470.
    PubMed    


  229. BARRETT MJ, Blair JC, Sperling SA, Smolkin ME, et al
    Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson disease.
    Neurology. 2018 Apr 4. pii: WNL.0000000000005421.
    PubMed     Abstract available


  230. KOO BB, Chow CA, Shah DR, Khan FH, et al
    Demoralization in Parkinson disease.
    Neurology. 2018 Apr 4. pii: WNL.0000000000005425.
    PubMed     Abstract available


  231. BOHNEN NI, Teipel SJ
    Cholinergic forebrain density loss in Parkinson disease: More than just cognitive changes.
    Neurology. 2018 Apr 4. pii: WNL.0000000000005408.
    PubMed    


    March 2018
  232. BOLLAND MJ, Avenell A, Gamble G, Grey A, et al
    Reader response: Expression of Concern: Does compensatory hyperparathyroidism predispose to ischemic stroke? Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy; An alternative to vitamin D supplementation to
    Neurology. 2018;90:627-628.
    PubMed    


  233. KARAM C, Galetta S
    Editors' note: Expression of Concern: Does compensatory hyperparathyroidism predispose to ischemic stroke? Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy; An alternative to vitamin D supplementation to p
    Neurology. 2018;90:627.
    PubMed    


  234. ROY HA, Aziz TZ, Fitzgerald JJ, Green AL, et al
    Beta oscillations and urinary voiding in Parkinson disease.
    Neurology. 2018 Mar 23. pii: WNL.0000000000005355.
    PubMed     Abstract available


  235. FRATTINI E, Monfrini E, Bitetto G, Ferrari B, et al
    Clinical Reasoning: A 75-year-old man with parkinsonism, mood depression, and weight loss.
    Neurology. 2018;90:572-575.
    PubMed    


  236. BRODSKY M, Lahna D, Pollock J, Pettersson D, et al
    Nigrosome 1 absence in de novo Parkinson disease.
    Neurology. 2018;90:522-523.
    PubMed    


    February 2018
  237. DIRKX MF, Zach H, Bloem BR, Hallett M, et al
    The nature of postural tremor in Parkinson disease.
    Neurology. 2018 Feb 23. pii: WNL.0000000000005215.
    PubMed     Abstract available


  238. HASSAN A
    No handshake agreement on postural tremor subtypes in Parkinson disease?
    Neurology. 2018 Feb 23. pii: WNL.0000000000005199.
    PubMed    


  239. PILOTTO A, Premi E, Paola Caminiti S, Presotto L, et al
    Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease.
    Neurology. 2018 Feb 16. pii: WNL.0000000000005161.
    PubMed     Abstract available


  240. WEISS D, Massano J
    Approaching adaptive control in neurostimulation for Parkinson disease: Autopilot on.
    Neurology. 2018 Feb 14. pii: WNL.0000000000005111.
    PubMed    


  241. ARLOTTI M, Marceglia S, Foffani G, Volkmann J, et al
    Eight-hours adaptive deep brain stimulation in patients with Parkinson disease.
    Neurology. 2018 Feb 14. pii: WNL.0000000000005121.
    PubMed     Abstract available


  242. HONMA M, Masaoka Y, Kuroda T, Futamura A, et al
    Impairment of cross-modality of vision and olfaction in Parkinson disease.
    Neurology. 2018 Feb 7. pii: WNL.0000000000005110.
    PubMed     Abstract available


    January 2018
  243. MURATA M, Odawara T, Hasegawa K, Iiyama S, et al
    Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized, double-blind phase 2 study.
    Neurology. 2018 Jan 24. pii: WNL.0000000000005010.
    PubMed     Abstract available


  244. HERSHEY LA, Irwin DJ
    Zonisamide for DLB parkinsonism: An old drug used in a new context.
    Neurology. 2018 Jan 24. pii: WNL.0000000000005006.
    PubMed    


  245. LEE PC, Ahmed I, Loriot MA, Mulot C, et al
    Smoking and Parkinson disease: Evidence for gene-by-smoking interactions.
    Neurology. 2018 Jan 19. pii: WNL.0000000000004953.
    PubMed     Abstract available


  246. DAVIS JL, Kurek JA, Morgan JC, Sethi KD, et al
    Teaching Video NeuroImages: Oculogyric crisis in treated Parkinson disease.
    Neurology. 2018;90:e263.
    PubMed    


  247. MUNOZ DG, Fujioka S
    Caffeine and Parkinson disease: A possible diagnostic and pathogenic breakthrough.
    Neurology. 2018 Jan 3. pii: WNL.0000000000004898.
    PubMed    


  248. FUJIMAKI M, Saiki S, Li Y, Kaga N, et al
    Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease.
    Neurology. 2018 Jan 3. pii: WNL.0000000000004888.
    PubMed     Abstract available


    December 2017
  249. BARTHEL C, Nonnekes J, van Helvert M, Haan R, et al
    The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2017 Dec 20. pii: WNL.0000000000004795.
    PubMed     Abstract available


  250. ROSSO AL, Bohnen NI, Launer LJ, Aizenstein HJ, et al
    Vascular and dopaminergic contributors to mild parkinsonian signs in older adults.
    Neurology. 2017 Dec 15. pii: WNL.0000000000004842.
    PubMed     Abstract available


  251. MELE B, Holroyd-Leduc J, Smith EE, Pringsheim T, et al
    Detecting anxiety in individuals with Parkinson disease: A systematic review.
    Neurology. 2017 Dec 6. pii: WNL.0000000000004771.
    PubMed     Abstract available


  252. FERRER P, Montoya J, Garcia Ruiz PJ
    Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2017;89:e272-e273.
    PubMed    


  253. BROCKMANN K, Lerche S, Dilger SS, Stirnkorb JG, et al
    SNPs in Abeta clearance proteins: Lower CSF Abeta1-42 levels and earlier onset of dementia in PD.
    Neurology. 2017;89:2335-2340.
    PubMed     Abstract available


  254. DAHODWALA N, Shah K, He Y, Wu SS, et al
    Sex disparities in access to caregiving in Parkinson disease.
    Neurology. 2017 Dec 1. pii: WNL.0000000000004764.
    PubMed     Abstract available


    November 2017
  255. CENTI J, Freeman R, Gibbons CH, Neargarder S, et al
    Author response: Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2017;89:2122.
    PubMed    


  256. GUARALDI P, Poda R, Calandra-Buonaura G, Solieri L, et al
    Letter re: Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2017;89:2122.
    PubMed    


  257. DODEL R
    beta-Amyloid pathology and Parkinson disease.
    Neurology. 2017 Nov 8. pii: 10.1212/WNL.0000000000004756.
    PubMed    


  258. WHITWELL JL, Weigand SD, Duffy JR, Clark HM, et al
    Predicting clinical decline in progressive agrammatic aphasia and apraxia of speech.
    Neurology. 2017 Nov 1. pii: 10.1212/WNL.0000000000004685.
    PubMed     Abstract available


    October 2017
  259. CUMMING K, Macleod AD, Myint PK, Counsell CE, et al
    Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2017 Oct 27. pii: 10.1212/WNL.0000000000004691.
    PubMed     Abstract available


  260. MOLLENHAUER B, Caspell-Garcia CJ, Coffey CS, Taylor P, et al
    Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.
    Neurology. 2017 Oct 13. pii: 10.1212/WNL.0000000000004609.
    PubMed     Abstract available


  261. UC EY, Rizzo M, O'Shea AMJ, Anderson SW, et al
    Longitudinal decline of driving safety in Parkinson disease.
    Neurology. 2017 Oct 11. pii: 10.1212/WNL.0000000000004629.
    PubMed     Abstract available


  262. TABUAS-PEREIRA M, Santana I, Santo GC
    Clinical Reasoning: A 55-year-old man with rapidly progressive dementia and parkinsonism.
    Neurology. 2017;89:e182-e187.
    PubMed    


  263. BRODSKY MA, Anderson S, Murchison C, Seier M, et al
    Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2017 Oct 6. pii: 10.1212/WNL.0000000000004630.
    PubMed     Abstract available


  264. AZIZ TZ, Hariz M
    To sleep or not to sleep during deep brain stimulation surgery for Parkinson disease?
    Neurology. 2017 Oct 6. pii: 10.1212/WNL.0000000000004635.
    PubMed    


    September 2017
  265. LEEHEY M, Luo S, Sharma S, Wills AA, et al
    Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores.
    Neurology. 2017 Sep 29. pii: 10.1212/WNL.0000000000004572.
    PubMed     Abstract available


  266. HEDERA P, Davis TL
    Can lifestyle modification slow progression of Parkinson disease?
    Neurology. 2017 Sep 29. pii: 10.1212/WNL.0000000000004580.
    PubMed    


  267. POSTUMA RB, Anang J, Pelletier A, Joseph L, et al
    Caffeine as symptomatic treatment for Parkinson disease (Cafe-PD): A randomized trial.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004568.
    PubMed     Abstract available


  268. MOREAU C, Barton BR, Devos D
    Virtually reducing fall risk in Parkinson disease.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004581.
    PubMed    


  269. MAIDAN I, Rosenberg-Katz K, Jacob Y, Giladi N, et al
    Disparate effects of training on brain activation in Parkinson disease.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004576.
    PubMed     Abstract available


  270. THORMANN A, Sorensen PS, Koch-Henriksen N, Laursen B, et al
    Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality.
    Neurology. 2017 Sep 20. pii: 10.1212/WNL.0000000000004508.
    PubMed     Abstract available


  271. SHAMIR R, Klein C, Amar D, Vollstedt EJ, et al
    Analysis of blood-based gene expression in idiopathic Parkinson disease.
    Neurology. 2017 Sep 15. pii: 10.1212/WNL.0000000000004516.
    PubMed     Abstract available


  272. LECLAIR-VISONNEAU L, Clairembault T, Coron E, Le Dily S, et al
    REM sleep behavior disorder is related to enteric neuropathology in Parkinson disease.
    Neurology. 2017 Sep 8. pii: 10.1212/WNL.0000000000004496.
    PubMed     Abstract available


  273. BOWMAN GL
    Biomarkers for early detection of Parkinson disease: A scent of consistency with olfactory dysfunction.
    Neurology. 2017 Sep 6. pii: 10.1212/WNL.0000000000004383.
    PubMed    


  274. CHEN H, Shrestha S, Huang X, Jain S, et al
    Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2017 Sep 6. pii: 10.1212/WNL.0000000000004382.
    PubMed     Abstract available


  275. SEARLES NIELSEN S, Warden MN, Camacho-Soto A, Willis AW, et al
    A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2017 Sep 1. pii: 10.1212/WNL.0000000000004536.
    PubMed     Abstract available


    August 2017
  276. FULLARD ME, Thibault DP, Hill A, Fox J, et al
    Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2017 Aug 23. pii: 10.1212/WNL.0000000000004355.
    PubMed     Abstract available


  277. NOLANO M, Provitera V, Manganelli F, Iodice R, et al
    Loss of cutaneous large and small fibers in naive and l-dopa-treated PD patients.
    Neurology. 2017;89:776-784.
    PubMed     Abstract available


  278. SHPRECHER DR, Majersik JJ
    The virtual house call: A 21st-century innovation in the care of patients with Parkinson disease.
    Neurology. 2017 Aug 16. pii: 10.1212/WNL.0000000000004366.
    PubMed    


  279. BECK CA, Beran DB, Biglan KM, Boyd CM, et al
    National randomized controlled trial of virtual house calls for Parkinson disease.
    Neurology. 2017 Aug 16. pii: 10.1212/WNL.0000000000004357.
    PubMed     Abstract available


  280. VERHAGEN METMAN L, Espay AJ
    Teaching Video NeuroImages: The underrecognized diphasic dyskinesia of Parkinson disease.
    Neurology. 2017;89:e83-e84.
    PubMed    


  281. CURY RG, Fraix V, Castrioto A, Perez Fernandez MA, et al
    Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia.
    Neurology. 2017 Aug 2. pii: 10.1212/WNL.0000000000004295.
    PubMed     Abstract available


    July 2017
  282. REGENSBURGER M, Turk M, Pagenstecher A, Schroder R, et al
    VCP-related multisystem proteinopathy presenting as early-onset Parkinson disease.
    Neurology. 2017 Jul 19. pii: 10.1212/WNL.0000000000004240.
    PubMed    


  283. IRANZO A, Stefani A, Serradell M, Marti MJ, et al
    Characterization of patients with longstanding idiopathic REM sleep behavior disorder.
    Neurology. 2017;89:242-248.
    PubMed     Abstract available


  284. JACOVA C, Factor SA
    Phosphodiesterase 4: Rethinking cognition in Parkinson disease.
    Neurology. 2017 Jul 12. pii: 10.1212/WNL.0000000000004221.
    PubMed    


  285. NICCOLINI F, Wilson H, Pagano G, Coello C, et al
    Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.
    Neurology. 2017 Jul 12. pii: 10.1212/WNL.0000000000004201.
    PubMed     Abstract available


  286. SIERRA M, Martinez-Rodriguez I, Sanchez-Juan P, Gonzalez-Aramburu I, et al
    Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-associated Parkinson disease.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004185.
    PubMed     Abstract available


  287. CILIA R, Laguna J, Cassani E, Cereda E, et al
    Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004175.
    PubMed     Abstract available



  288. Decrease in Abeta42 predicts dopa-resistant gait progression in early Parkinson disease.
    Neurology. 2017;89:107.
    PubMed    


    June 2017
  289. HUGHES KC, Gao X, Kim IY, Wang M, et al
    Intake of dairy foods and risk of Parkinson disease.
    Neurology. 2017 Jun 8. pii: 10.1212/WNL.0000000000004057.
    PubMed     Abstract available


  290. RAJPUT AH, Rajput ML, Ferguson LW, Rajput A, et al
    Baseline motor findings and Parkinson disease prognostic subtypes.
    Neurology. 2017 Jun 7. pii: 10.1212/WNL.0000000000004078.
    PubMed     Abstract available


    May 2017
  291. MARKOVIC V, Agosta F, Canu E, Inuggi A, et al
    Role of habenula and amygdala dysfunction in Parkinson disease patients with punding.
    Neurology. 2017 May 10. pii: 10.1212/WNL.0000000000004012.
    PubMed     Abstract available


  292. STOCCHI F, Rascol O, Hauser RA, Huyck S, et al
    Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease.
    Neurology. 2017 May 10. pii: 10.1212/WNL.0000000000004003.
    PubMed     Abstract available


    April 2017
  293. LIU B, Fang F, Pedersen NL, Tillander A, et al
    Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study.
    Neurology. 2017 Apr 26. pii: 10.1212/WNL.0000000000003961.
    PubMed     Abstract available


  294. BORGHAMMER P, Hamani C
    Preventing Parkinson disease by vagotomy: Fact or fiction?
    Neurology. 2017 Apr 26. pii: 10.1212/WNL.0000000000003969.
    PubMed    


    March 2017
  295. PAKPOOR J, Noyce A, Goldacre R, Selkihova M, et al
    Viral hepatitis and Parkinson disease: A national record-linkage study.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003848.
    PubMed     Abstract available


  296. BENITO-LEON J
    Viral hepatitis and the risk of Parkinson disease.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003853.
    PubMed    


  297. ROCHESTER L, Galna B, Lord S, Yarnall AJ, et al
    Decrease in Abeta42 predicts dopa-resistant gait progression in early Parkinson disease.
    Neurology. 2017 Mar 22. pii: 10.1212/WNL.0000000000003840.
    PubMed     Abstract available


  298. SINGER W, Berini SE, Sandroni P, Fealey RD, et al
    Pure autonomic failure: Predictors of conversion to clinical CNS involvement.
    Neurology. 2017;88:1129-1136.
    PubMed     Abstract available


  299. NONNEKES J, Janssen S, Bloem BR
    Superficial brain stimulation to overcome freezing of gait in Parkinson disease.
    Neurology. 2017 Mar 15. pii: 10.1212/WNL.0000000000003859.
    PubMed    


  300. SAARI L, Kivinen K, Gardberg M, Joutsa J, et al
    Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease.
    Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003810.
    PubMed     Abstract available


    February 2017
  301. BUCHMAN AS, Bennett DA
    Author response: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:920.
    PubMed    


  302. BOHNEN NI, Muller M
    Letter re: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:920.
    PubMed    


  303. BUCHMAN AS, Bennett DA
    Author response: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:919-920.
    PubMed    


  304. MAHLKNECHT P, Kiechl S, Willeit J, Poewe W, et al
    Letter re: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:919.
    PubMed    


  305. GOLDMAN JG, Bledsoe IO, Merkitch D, Dinh V, et al
    Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease.
    Neurology. 2017 Feb 24. pii: 10.1212/WNL.0000000000003764.
    PubMed     Abstract available


  306. MERY VP, Gros P, Lafontaine AL, Robinson A, et al
    Reduced cognitive function in patients with Parkinson disease and obstructive sleep apnea.
    Neurology. 2017 Feb 22. pii: 10.1212/WNL.0000000000003738.
    PubMed     Abstract available


  307. LEWITT PA, Li J, Lu M, Guo L, et al
    Metabolomic biomarkers as strong correlates of Parkinson disease progression.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003663.
    PubMed     Abstract available


  308. ALVES G, Bonanni L
    Neurofilament light: A heavyweight diagnostic biomarker in neurodegenerative parkinsonism?
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003699.
    PubMed    


  309. HANSSON O, Janelidze S, Hall S, Magdalinou N, et al
    Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003680.
    PubMed     Abstract available


    January 2017
  310. EWENCZYK C, Mesmoudi S, Gallea C, Welter ML, et al
    Antisaccades in Parkinson disease: A new marker of postural control?
    Neurology. 2017 Jan 27. pii: 10.1212/WNL.0000000000003658.
    PubMed     Abstract available


  311. PEDERSEN KF, Larsen JP, Tysnes OB, Alves G, et al
    Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
    Neurology. 2017 Jan 20. pii: 10.1212/WNL.0000000000003634.
    PubMed     Abstract available


  312. FEDOROVA TD, Seidelin LB, Knudsen K, Schacht AC, et al
    Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11C-donepezil PET study.
    Neurology. 2017 Jan 18. pii: 10.1212/WNL.0000000000003633.
    PubMed     Abstract available


  313. KUBU CS, Cooper SE, Machado A, Frazier T, et al
    Insights gleaned by measuring patients' stated goals for DBS: More than tremor.
    Neurology. 2017;88:124-130.
    PubMed     Abstract available


    December 2016
  314. RACETTE BA, Searles Nielsen S, Criswell SR, Sheppard L, et al
    Dose-dependent progression of parkinsonism in manganese-exposed welders.
    Neurology. 2016 Dec 28. pii: 10.1212/WNL.0000000000003533.
    PubMed     Abstract available


  315. RATNER MH, Fitzgerald E
    Understanding of the role of manganese in parkinsonism and Parkinson disease.
    Neurology. 2016 Dec 28. pii: 10.1212/WNL.0000000000003543.
    PubMed    


  316. THOLFSEN LK, Larsen JP, Schulz J, Tysnes OB, et al
    Changes in insomnia subtypes in early Parkinson disease.
    Neurology. 2016 Dec 16. pii: 10.1212/WNL.0000000000003540.
    PubMed     Abstract available


    November 2016
  317. CENTI J, Freeman R, Gibbons CH, Neargarder S, et al
    Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003452.
    PubMed     Abstract available


  318. BOYLAN LS, Messinis L
    Orthostatic hypotension, cognition, and Parkinson disease: Dumbing down by standing up.
    Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003468.
    PubMed    


  319. MANO T, Britton Z, Britton T
    Anatomo-functional basis of nonmotor symptoms in Parkinson disease.
    Neurology. 2016 Nov 16. pii: 10.1212/WNL.0000000000003443.
    PubMed    


  320. PYATIGORSKAYA N, Mongin M, Valabregue R, Yahia-Cherif L, et al
    Medulla oblongata damage and cardiac autonomic dysfunction in Parkinson disease.
    Neurology. 2016 Nov 11. pii: 10.1212/WNL.0000000000003426.
    PubMed     Abstract available


  321. PAGANO G, Molloy S, Bain PG, Rabiner EA, et al
    Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease.
    Neurology. 2016 Nov 2. pii: 10.1212/WNL.0000000000003396.
    PubMed     Abstract available


    October 2016
  322. MATTIS PJ, Niethammer M, Sako W, Tang CC, et al
    Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.
    Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003285.
    PubMed     Abstract available


  323. BRYS M, Fox MD, Agarwal S, Biagioni M, et al
    Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease: A randomized trial.
    Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003279.
    PubMed     Abstract available


    September 2016
  324. UMEMOTO G, Fujioka S, Yanamoto S, Fukae J, et al
    A case of sudden deterioration in Parkinson disease.
    Neurology. 2016;87:1422.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: